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Introduction 
() R lei I N t\ L t\ RTICIX 
Acute pancreatitis after liver 
transplantation: incidence and 
contributing factors 
Abstract In order to assess the in-
cidence and possible predisposing 
and contributing factors in the de-
velopment of acute pancreatitis 
after liver transplantation. we re-
viewed the medical records of all 
1832 adult patients who underwent 
2161 orthotopic liver transplanta-
tion (OLTx) procedures in our cen-
ter between January 1987 and Sep-
tember 1992. Of these patients, 55 
(3 % incidence) developed clinical 
pancreatitis and 247 (13.4 % inci-
dence) developed hyperamylasemia 
(biochemical pancreatitis). Overall 
mortality in cases of clinical pan-
creatitis was 63.6 %. The mortality 
in cases of hyperamylasemia was si-
milar to that found in the general Ii-
ver transplant population (i. e., 
23 %). A strong correlation was 
found between pancreatitis after li-
ver transplantation and end-stage li-
ver disease due to hepatitis B (30 % 
of the cases. P = 0.00001). Extensive 
surgical dissection around the pan-
creas (P < 0.05). the type of biliary 
reconstruction following liver trans-
plantation (P < 0.05). and the num-
ber of liver grafts received by the 
same patient (P = 0.00001) ap-
peared to be possible contributing 
factors as did the duration of veno-
venous bypass and the quantity of 
IV calcium chloride administered 
intraoperatively. 
Key words Pancreatitis· Liver 
transplantation 
Pancreatitis constitutes one of the most severe compli-
cations following liver transplantation. In the general 
population, it has been postulated that ischemia [38], 
drugs (i.e .. steroids [3. 5, 23, 31], furosemide [7, 15,39]' 
unidentified viral infections [2,4). postoperative hyper-
parathyroidism. vasculitis. calcium chloride administra-
tion [21. 29. 36). and intraoperative trauma may all be 
contributing factors. Alexander et al. (1) reported a 
high incidence of post-OLTx (orthotopic liver trans-
plantation) pancreatitis in patients suffering from hepa-
titis B. In fact. a report from the same institution re-
vealed the magnitude of the problem and raised ques-
tions for further study [26). To gain further insight into 
this problem. a retrospective analysis of the incidence 
of post-OLTx pancreatitis was undertaken. A main ob-
jective was to identify the variables most strongly associ-
ated with pancreatitis after OLTx. 
Materials and methods 
From I January 1987 to 30 September 1992. 1832 patients under· 
went 2161 OLTx procedures at the Presbyterian University Hospi-
tal of Pittsburgh. Of these patients. 302 developed postoperative 
hyperamylasemia. and all of their records were reviewed. This re-
port deals with post-OLTx pancreatitis in the immediate post-
operative period (up to 30 days after OL Tx). In fact. most of these 
patients developed this complication during the 1st postoperative 
week. and mostly in the intensive care unit (ICU). Apart from he-
2 
patitis B-positive serology. which has been shown to predispose pa-
tients to the development of pancreatitis. no other preoperative 
contributing condition was identified. For the purpose of this 
study, patients with hyperamylasemia who had serum creatinine 
above 2 mg were excluded. since measurements of creatinine and 
amvlase clearance were lacking. 
'Amvlase was determined everv other dav in the immediate 
posttransplant period or more frequently wh~n indicated. Serum 
amylase measurements were performed using the Kodak Enzy-
matic Amvlase Kit (Eastman Kodak. Rochester. N.Y.). 
Clinical pancreatitis was defined as an elevatIOn of the serum 
amylase level in excess of twice the value of the normal upper lim-
it. plus any additional diagnostic CT scan findings (such as pancre-
atic enlargement or pseudocyst/abscess formation). intraoperative 
findings. or autopsy confirmation. Clinical findings were not con-
sidered because thev were ill-defined. Patients diagnosed as hav-
ing clinical pancreatitis were immediately brought to the ICU post-
operatively: most of them were on mechanical ventilation. Patients 
whose amylase levels were elevated to more than twice the normal 
upper limit. at least in one measurement. were defined as having 
hyperamylasemia (biochemical pancreatitis). This term was first 
used by Alexander et al. [1]. and we used it for all patients with hy-
peramylasemia who lacked the clinical or CT findings consistent 
with pancreatitis. Of course. the use of creatinine clearance values 
In the assessment of renal function is more reliable than that of se-
rum creatinine levels. However. we chose to use the 2-mg serum 
creatinine threshold. based on the above-mentioned reference by 
Alexander et al. Moreover. in this retrospective study. it was not 
feasible to obtain creatinine clearance values for all of our patients. 
All the patients who developed clinical pancreatitis wee put on 
either double or Single venovenous bypass. Double bypass is con-
sidered when the femoral and portal veins arc brought together to 
a centripetal pump (Bio-Medicus. Minnetonka. Minn.) and the re-
turn flow is connected to the axillary vein. Single bypass was the 
choice in cases of previous portocaval shunts or portal vein throm-
bosis or when the portal vein was unsuitable for double bypass. The 
liver grafts were harvested according to the techntque described by 
Starzl et al. [33]. 
From 1987 until 1989 cyclosporin (Cy A) plus steroids was the 
standard immunosuppressive treatment for liver recipients. For re-
jection episodes a bolus dose of steroids was admintstered intrave-
nously. followed by a steroid recvcling protocol. If there was no re-
sponse. a course of OKT3 was given intravenously. Starting in 
1989. FK 506 replaced Cv A in the protocols used. and the steroid 
doses were significant Iv lowered because of the greater FK 506 po-
tency. The antirejecllon treatment remained unchanged. Cntil bo-
wel function had resumed. lipids in the form of total parenteral nu-
trition (TPN) were administered as a postoperative rule. No differ-
ence was found regarding the incidence or severity of pancreatitis 
between groups of patients treated with Cy A and those treated 
with FK 506. In all patients undergOing surgical treatment. intraab-
dominal sepsis was documented preoperatively. 
Neither Ranson score nor other criteria were used to assess the 
severity of pancreatitis. since most of these are greatly deranged 
following liver transplantation. The therapeutic choice was based 
mostly on the abdominal CT findings. Furthermore. in most of the 
cases dynamic CT pancreatography was carried out in order to as-
sess the extent of the necrosis. 
Treatment of clinical pancreatitis was either medical or surgi-
cal. Surgical treatment Included simple drainagc. debridement. or 
pancreatectomy. 
Statistical analysis was performed using Student's t -test for un-
paired samples. The chi-square method was used to evaluate the 
association and the differences In proportions. A P value below 
0.05 was considered to be significant. 
Results 
Of the 1832 patients who were studied. 302 (16.4 %) de-
veloped hyperamylasemia during the postoperative 
course of OLTx without renal insufficiency (serum crea-
tinine < 2 mg %). Of these. 55 (3 %) developed clinical 
pancreatitis: in the other 247 patients. amylase levels 
eventuallv returned to normal. 
Of the 55 patients who developed clinical pancreati-
tis. 17 (30.9 %) had been transplanted because of hepati-
tis B cirrhosis. as compared to 114 (6.2 %) of the total 
number of liver transplant recipients who had been 
transplanted for the same reason. Fifteen patients who 
later developed clinical pancreatitis (27.3 %) had been 
transplanted for hepatitis non-A non-B cirrhosis. as 
against 340 (18.6 %) of the total number of liver trans-
plant recipients. Eight patients (14.5 %) versus 
172 patients (9.4 %) had been transplanted for primary 
biliary cirrhosis. while 7 (12.7 %) versus 310 (16.9 %) 
had been transplanted for alcoholic cirrhosis. Three pa-
tients (5.4 %) versus six (0.3 %) had been transplanted 
for fulminant hepatic failure related to drug overdose. 
Two patients (3.6 %) versus 129 (7.0 %) had been trans-
planted for primary sclerosing cholangitis. Two patients 
(3.6 %) versus 82 (4.5 %) had been transplanted for he-
patocellular carcinoma. Finally. 1 patient who devel-
oped clinical pancreatitis (1.8 'Yo) versus 59 (3.2 %) of 
the total number of liver transplant recipients had been 
transplanted for autoimmune hepatitis (Fig. 1). This dis-
tribution of diseases necessitating OL Tx among patients 
who later developed clinical pancreatitis was statistical-
ly highly significant (P = a.aooO!) compared with the 
distribution among all liver transplant recipients. 
Of the 55 patients with clinical pancreatitis. 
40 (72.7 %) had received FK 506 plus steroids as immu-
nosuppressive treatment. and 15 (27.2 %) had received 
CyA plus steroids. All of the patients had also been trea-
ted with furosemide. 
The annual distribution of these 55 cases of post-
OL Tx pancreatitis was: ~ patients ( 14.5 %) for the vear 
1987, 5 patients (9%) for the year 1988, 12 pati'ents 
(21.8 %) for the year 1989. 12 ptients (21.8 %) for the 
year 1990, 13 patients (23.6 %) for the year 1991, and 
5 patients (9 %) for the first Y months of 1992. This dis-
tribution is not statistically significant compared to the 
annual distribution of OLTx procedures for the entire 
liver transplant population during the same time period 
(Table 1). The mean age of these 55 patients was 
47.1 years (SD ± 14.2). with a range between 20 and 
69 years. The mean age of all liver transplant patients 
was 47.0 vears (SO ± 12.7). The difference between the 
two groups is not statistically significant. The distribu-
tion according to age groups is shown in Fig. 2. 
Twenty-nine (52.7 %) of the 55 patients who devel-
oped post-OL Tx pancreatitis had received primary li-
ver grafts. Twenty patients (36.3 %) developed pancrea-
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Fig.1 Distribution of primary 
diseases leading to liver trans-
plantation in the group of pa-
tients who developed clinical 
pancreatitis (.; n = 55) and in 
the total number of liver trans-
plant recipients E~ n = 1832). 
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Table 1 Patient data 
Age 
(years) 
Mean 47.1 
SD± 14.2 
Range 20-69 
P=NS 
a First I} months 
Sex 
M 33 (60%) 
F22(40%) 
Ratio M: F 1.5: 1 
P=NS 
History of 
alcoholism 
Yes 12 (21.8 %) 
N043 (79.1 %) 
titis after receiving their second liver graft. and 6 pa-
tients (10.2 %). after they had received their third liver 
transplant. Statistically. this proved to by highly signifi-
cant since. during the same time period. 72 % of the to-
tal number of liver transplants were primary grafts 
(P = 0.00001: Table 1: Fig. 3). 
The postoperative day (POD) on which hyperamyla-
semia developed was on the average POD 2.2 
(SD ± 1.9): it ranged from the day of transplantation to 
POD 10. The diagnosis of clinical pancreatitis. which 
was confirmed either by cr scan (enlargement of the 
pancreas, pseudocyst. abscess) or during the operation 
or at autopsy, was established on mean POD 4.7 
(SD ± 3): this ranged from POD 1 to POD 11 (Table 2). 
All 55 patients had a venovenous bypass. either dou-
ble or single: the mean duration was 98.1 min 
(SD ± 29). the range 45-198 min. Twenty-nine patients 
(52.7 %) were on bypass for less than 1 h 30 min: 
26 patients (47.2 %) were on bypass beyond this limit 
(Table 2). 
Type of transplants in 
pancreatitis group (n = 55) 
1st 29 (52.7%) 
2nd 20 (36.3 %) 
3rd 6 (10.2 %) 
> 3rd 0 (0%) 
p=o.ooo:n 
No. of transplants 
followed by pancrea-
titis per year (n = 55) 
1987 8(14.5%) 
1988 5 (9.09%) 
1989 12 (21.8 %) 
1990 12 (21.8 %) 
1991 13 (23.6%) 
1992" 5 (9.09%) 
P=NS 
Regarding the biliary reconstruction. 40 patients 
(72.7 %) had a Roux-en-Y stented choledochojejunos-
tomy and 15 patients (27.2 %) had a donor-recipient 
duct-to-duct anastomosis over a T tube. This distribu-
tion is statistically significant (P < 0.05) compared with 
the total number of liver transplant recipients in whom 
only 52 % of the biliary reconstructions were per-
formed in a Roux-en-Y fashion (Table 2). 
Portal vein thrombosis was identified in 10 patients 
(18.1 %),4 of whom (7.2 %) had a thrombectomy and 6 
(10.9 %). a venous graft. Of the 6 who received grafts. 4 
had interposition grafts and 2, jump grafts from the su-
perior mesenteric vein to portal vein (Table 2). In the 
general liver transplant population. a portal venous 
graft was used in approximately 2.85 % of the cases 
(P <0.002). 
The frequency of an arterial graft from the infrarenal 
aorta (brought either anteriorly or posteriorly to the 
pancreas) to the donor hepatic artery was high. and this 
occurred in 24 patients (43.6 %: Table 2). In the general 
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liver transplant population. the overall incidence of the 
use of an arterial graft for the reperfusion of the liver al-
lograft was 17 % during the same period (P < 0.(01). 
Splenectomy at the time of the OLTx was carried out 
in 2 patients (3.6 %). and ligation of the celiac axis was 
performed in another two patients (3.6 %). Dissection 
of the region of the splenic artery or the celiac axis was 
carried out in a (16.3 %) and 8 (10.9 %) patients, respec-
tively. 
The use of lipids in the TPN solution was consistent 
for all patients. The mean duration was 4.5 days 
(SO ± 3.4) and the range 1-20 days postoperatively or 
until the time pancreatitis developed. 
Thirty-six of the 55 patients (65.4 %) received medi-
cal treatment and the other 19 (34.5 %) underwent sur-
gical treatment. Depending on the operative findings, 
surgical treatment consisted in simple drainage, open 
20-30 
years 
3 
(5.45%) 
40-50 
years 
Age groups 
SO-50 
years 
16 
(29.09%) 
>60 
years 
abdomen. or pancreatectomy. Three patients were trea-
ted by regional pancreatectomy: 2 of them died and 1 
survived (Table 2). Sixteen patients (29 %) presently re-
main well with the graft they had at the time pancreatitis 
developed; all of these patients received medicamen-
tous treatment. Four patients (7.2 %) remain well with 
another graft that was transplanted during or after the 
episode of pancreatitis; of these, 2 received medical 
and the other 2 surgical treatment. Overall mortality 
was 63.6 % (35 patients). The mortality among the surgi-
cally treated patients was 89 % (17 patients), whereas 
50 % of the medically treated patients survived this 
complication (Fig. 4). 
Discussion 
The incidence of pancreatitis after OLTx depends on 
the criteria used to define this complication. Proven 
pancreatitis, confirmed by evidence obtained from cr 
scan, operation, or autopsy, has been reported to vary 
between 0.12 % and 17 % following renal transplanta-
tion [8, 10, 14, 25, 28, 35] and cardiac surgery [18, 24, 
26,29,34] and has been associated with high mortality 
rates ranging between 20 % and 70 % [8, 10, 14, 25, 28, 
35]. The above data are consistent with our findings con-
cerning the incidence of pancreatitis, which was 3 % 
among the total number of liver transplant recipients; 
the mortality rate was 63.6 %. The incidence of bio-
chemical pancreatitis, which was 16.4 %, did not appear 
to agree with the higher figures observed following car-
diac surgery [16, 24, 26, 29, 34]. 
In our study we found that several factors contribu-
ted to the incidence of post-OLTx acute pancreatitis. 
Noteworthy among our observations was the high inci-
dence of hepatitis B cirrhosis as a liver disease that 
leads to liver transplantation. One third of the patients 
Table 2 Clinical data (relx retransplantation) 
Postoperative 
dav on which 
hyperamvlase-
mta started 
Mean 2.2 
SO ± 1.4 
Range 0-10 
* p < 0.05 
** P<O.01 
*** P < 0.002 
40 36 
(654 %) 
35 
30 
VI 25 C 
.!!! 
8. 20 
'0 
0 15 Z 
10 
5 
0 
Postoperat1\'e 
dav on which 
clinical pan-
creat i t is was 
diagnosed 
Mean 4.7 
SD±3 
o 
Well Without 
Use of "eno-
venous 
hypass (min) 
Mean 9Kl 
SO ±19 
Range 45-19/0: 
2 2 
(36%)(36 %) 
Weliwlth 
~-~ ~-~ 
Outcome groups 
Tvpe of biliary 
reconstruction * 
Duct-to-duct 
15 (27.2')'0) 
Roux-en- Y 40 
(72.7%) 
Death 
ci~K4 Relation hetween kind of treatment and outcome (. medi-
cal. 123 surgical treatment) 
who developed post-OLTx pancreatitis were in this 
group of patients. This finding is particularly significant 
and is consistent with the view of Alexander et al. [1]. 
The distribution of pancreatitis cases among age 
groups (Fig. 2) was found to be high in the third decade 
of life: this declined in the fourth decade and rose again 
in the fifth and the sixth decades. This is a very impor-
tant observation. because this severe and possibly le-
thal complication occurs with a relatively high inci-
dence in the 30- to 40-year age group. 
Another interesting observation was that 36.3 % of 
the patients had alr;ady received their second liver 
transplant when pancreatitis developed (Fig. 3). A possi-
Use of 
arterial gra ft "'* 
Yes 24 143.6 'X.) 
No31 (56.3%) 
Portal vein 
thromhosis*** 
Patients 
IO(IS.I'Yo) 
Thromhectom\' 
4(7.2%) 
Venous grail 
6(10.9%) 
Intraoperative 
i.v.Cael, 
Mean 7.9 
SD±H 
Range 1.5-10 
Treatment 
and outcome 
Surgical 
19(34.5%) 
Medical 
36 (65.4 %) 
Death 
35 (63.6%) 
Wcll+retx·1 
4 (7.2 %) 
Well-retxh 
16 (29%) 
.1 Patients who survi\'ed the episode hut needed retransplantation 
h Patients who survived the episode with original transplant 
ble explanation for this could be the magnitude of the 
peripancreatic dissection that is necessary when the pa-
tient undergoes OL Tx for the second or third time 
(P = 0.(0001). 
All of the 55 patients were on venovenous bypass 
during the OL Tx operations. and of these 47.2 % were 
on bypass for more than the average duration of 
90 min. There is a statistically significant difference be-
tween this group and the group that was on bypass for 
less than 90 min (P < 0.05). This is consistent with the 
knowledge that extracorporeal bypass causes ischemia 
and subsequent injury to the pancreas as a result of the 
hypotension and low cardiac output that is observed 
during bypass and that is strongly related to the dura-
tion of the bypass [17.22.27.30.32.381. 
Furthermore. it is very significant that 40 patients 
(72.7 %) had their biliary reconstruction in the form of 
the donor bile duct to a recipient Roux-en- Y loop. This 
high proportion seems to be an important contributing 
factor for the occurrence of pancreatitis. We observed a 
higher incidence of portal vein thrombosis (18.1 %) in 
the pancreatitis group. This is probably related to the 
dissection and unavoidable surgical manipulations in 
the peripancreatic region during the thrombectomy 
and to the need for a venous jump graft construction. 
A strong correlation was found between the high in-
cidence (43.6 %) of the construction of an arterial graft 
in the pancreatitis group and the subsequent develop-
ment of post-OL Tx pancreatitis. The extensive peripan-
creatic dissection that is necessary when an arterial graft 
is to be constructed appears to be an important contri-
buting factor. This may also be true in cases where liga-
tion or dissection of the celiac axis is carried out. It is 
well known that these surgical manipulations cause me-
6 
chanical trauma in the peripancreatic region. The inci-
dence of pancreatitis in relation to the two immunosup-
pressive regimens that were used - either FK 506 plus 
steroids or Cy A plus steroids - was of no statistical sig-
nificance. Therefore. since FK 506 replaced CyA start-
ing in 1989. it can be assumed that the pancreatitis distri-
bution was not higher with either immunosuppressive 
agent. This finding reversed the initial hope that the in-
troduction of the FK S06 would lower the incidence of 
post-OL Tx pancreatitis. since it allows for the use of 
lower doses of steroids. 
It is also noteworthy that all of the patients were re-
ceiving larl!e doses of furosemide. which like steroids. is 
well kDlow~ to be associated with pancreatitis [3. 5. 7. 
15.23.31. 39]. 
Among the factors associated with post-OLTx pan-
creatitis was the intraoperative administration of cal-
cium chloride. The risk of pancreatitis induced by cal-
cium chloride is dose related. Although even a close cor-
relation such as this cannot confirm a cause-and-effect 
relation. there is strong evidence from earlier clinical 
and experimental studies that there is a link between hy-
percalcemia and pancreatitis [6.9. 11-13. 17. 19.20.37]. 
These studies have shown that the administration of 
large doses of calcium chloride may contribute to the 
development of pancreatic cellular injury. The risk in-
creases rapidly when the dose is more than 1.5 g. Thus. 
in an attempt to reduce the incidence of pancreatic in-
jury and. ultimately. of severe pancreatitis. it seems pru-
dent to limit the dose of calcium chloride to 1.5 g in the 
absence of documentation of abnormally low levels of 
ionized calcium. Our observations are' in al!reement 
with these results. since all of our patients ~ith post-
OLTx pancreatitis had. in fact. received more than 
1.5 g of calcium chloride intraoperatively. 
Lipids did not appear to play an important role as a 
predisposing factor in the development of post-OLTx 
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